Patients with cancer commonly face complex medical decisions and unique challenges where language/communication is vital. This study aims to understand the impact of language and patient-provider language concordance on health care experiences and outcomes in the most common cancer in either sex: breast and prostate cancer.

Funded par the Canadian Institutes of Health Research (CIHR).